Noonan, M J <br/><br/>
Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.  [electronic resource] 

 -  The European respiratory journal  Jun 1998 
 - 1232-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0903-1936 
<br/><br/><label>Standard No.: </label>10.1183/09031936.98.11061232  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Adolescent<br/>Adult<br/>Aged<br/>Asthma--drug therapy<br/>Chronic Disease<br/>Cyclopropanes<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Forced Expiratory Volume--drug effects<br/>Humans<br/>Leukotriene Antagonists<br/>Male<br/>Middle Aged<br/>Peak Expiratory Flow Rate--drug effects<br/>Quality of Life<br/>Quinolines--administration & dosage<br/>Spirometry<br/>Sulfides